1 | 4-Aminosalicylic acid extended release granules | 1件: Aminosalicylic acid Aminosalicylic acid | 1件: D00162
D00162
| - | - | 1件: 96 96 |
2 | Aceneuramic Acid Extended-Release | 1件: Aceneuramic acid Aceneuramic acid | 1件: D11016
D11016
| - | - | 1件: 30 30 |
3 | Aceneuramic acid extended-release (Ace-ER) | 1件: Aceneuramic acid Aceneuramic acid | 1件: D11016
D11016
| - | - | 1件: 30 30 |
4 | Aceneuramic Acid Extended-Release Tablets | 1件: Aceneuramic acid Aceneuramic acid | 1件: D11016
D11016
| - | - | 1件: 30 30 |
5 | ADS-5102 (extended release amantadine HCl) | 1件: Amantadine Amantadine | 1件: D07441
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
6 | Advagraf prolonged-release hard capsules | 2件: Manganese citrate Manganese citrate (Synonym: Release), Tacrolimus | 2件: D00107
D00107
,
D08556
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
7 | ALKS 8700 Delayed Release (DR) | 1件: Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | 1件: 13 13 |
8 | ALKS 8700 Delayed Release (DR) Capsule | 1件: Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | 1件: 13 13 |
9 | Amantadine HCl Extended Release | 1件: Amantadine Amantadine | 1件: D07441
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
10 | Amantadine HCl Extended Release Capsule | 1件: Amantadine Amantadine | 1件: D07441
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
11 | Antioxidant plus Pregabalin (Synonym: PREGABALIN EXTENDED RELEASE) | 1件: Pregabalin Pregabalin (Synonym: Pregabalin Extended Release) | 1件: D02716
D02716
(Name: PREGABALIN EXTENDED RELEASE) | 4件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 | 7件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬 | 1件: 298 298 |
12 | APRISO 375 mg extended-release capsules | 1件: Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | 1件: 97 97 |
13 | Arbaclofen Extended Release Tablets | 1件: Arbaclofen Arbaclofen | 1件: D09791
D09791
| 2件: GABBR1 GABBR1, GABBR2 💬 | 7件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 |
14 | Asacol (mesalamine) Delayed-release Tablets | 1件: Mesalazine Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | 1件: D00377
D00377
| - | - | 1件: 97 97 |
15 | Asacol Delayed Release Tablets | 2件: Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | 1件: D00377
D00377
| - | - | 1件: 97 97 |
16 | Asacol Delayed-Release Tablets | 2件: Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | 1件: D00377
D00377
| - | - | 1件: 97 97 |
17 | AZD3241 Extended release tablets 100 mg | 1件: Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | 1件: 6 6 |
18 | AZD3241 Extended release tablets 25 mg | 1件: Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | 1件: 6 6 |
19 | Beraprost Sodium 314d Modified Release Tablets | 1件: Beraprost Beraprost | 1件: D02720
D02720
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
20 | Beraprost Sodium Modified Release | 1件: Beraprost Beraprost | 1件: D02720
D02720
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
21 | Budesonide 6 mg prolonged-release capsule, hard (BUX-PVII prototype) | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
22 | Budesonide 6 mg prolonged-release capsules, hard (BUX-PVII prototype) | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
23 | Budesonide 9 mg prolonged-release capsule, hard (BUX-PVII prototype) | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
24 | Budesonide 9 mg prolonged-release capsules, hard (BUX-PVII prototype) | 1件: Budesonide Budesonide | 1件: D00246
D00246
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
25 | Bydureon 2 mg powder and solvent for prolonged-release suspension | 2件: Exenatide Exenatide, Manganese citrate (Synonym: Release) | 1件: D04121
D04121
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 6 6 |
26 | Carbidopa and Levodopa Controlled Release Tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
27 | Carbidopa/Levodopa, immediate release | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
28 | Continuous Release Dopamine Agonists | 1件: Dopamine Dopamine | 1件: D07870
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
29 | Controlled-release levodopa / carbidopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
30 | Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) | 6件: Acetate Acetate, Cortisone acetate, Dexamethasone, Hydrocortisone, Prednisolone, Prednisone | 5件: D00088
D00088
,
D00292
,
D00472
,
D00473
,
D00973
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
31 | Cystagon (cysteamine bitartrate) immediate-release capsules | 1件: Cysteamine Cysteamine (Synonym: PROCYSBI Delayed-release) | 1件: D03634
D03634
| - | - | 1件: 299 299 |
32 | Cysteamine Bitartrate Delayed-release Capsules | 1件: Cysteamine Cysteamine (Synonym: PROCYSBI Delayed-release) | 1件: D03634
D03634
| - | - | 1件: 19 19 |
33 | Cysteamine Bitartrate Delayed-release Capsules (RP103) | 1件: Cysteamine Cysteamine (Synonym: PROCYSBI Delayed-release) | 1件: D03634
D03634
| - | - | 1件: 19 19 |
34 | Dalfampridine ER, 10 Mg Oral Tablet, Extended Release | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
35 | Deferiprone 600 mg delayed release tablet | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 6 6 |
36 | Delayed and extended release mesalazine | 1件: Mesalazine Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | 1件: D00377
D00377
| - | - | 1件: 97 97 |
37 | Delayed Release 6 mercaptopurine | 1件: Mercaptopurine Mercaptopurine | 2件: D00161
D00161
,
D04931
| 1件: HPRT1 HPRT1 💬 | 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Nucleotide metabolism, Purine metabolism 💬 | 1件: 96 96 |
38 | Delayed Release 6MP or Calcitriol vs. Purinethol | 1件: Calcitriol Calcitriol | 1件: D00129
D00129
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 96 96 |
39 | Diazoxide choline controlled-release tablet | 2件: Choline Choline (Synonym: Timed Release Vita-vim Srt), Diazoxide | 2件: D00294
D00294
,
D07690
| 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 1件: 193 193 |
40 | Dual release hydrocortisone (plenadren) | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
41 | Efmody 10 mg modified release hard capsules | 2件: Hydrocortisone Hydrocortisone, Manganese citrate (Synonym: Release) | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
42 | Efmody 5 mg modified release hard capsules | 2件: Hydrocortisone Hydrocortisone, Manganese citrate (Synonym: Release) | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
43 | Epilim Chrono 200 Controlled Released tablets | - | - | - | - | 1件: 256 256 |
44 | Epilim Chrono 300 Controlled Released tablets | - | - | - | - | 1件: 256 256 |
45 | Epilim Chrono 500 Controlled Released tablets | - | - | - | - | 1件: 256 256 |
46 | Exenatide extended release 2mg (Bydureon) | 1件: Exenatide Exenatide | 1件: D04121
D04121
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 6 6 |
47 | Extended release dipyridamole 200mg/aspirin 25mg | 2件: Acetylsalicylic acid Acetylsalicylic acid (Synonym: Aspirin 81mg Enteric coated Delayed Release), Dipyridamole (Synonym: Aspirin and Dipyridamole Extended Release) | 2件: D00109
D00109
,
D00302
| 4件: PDE4A PDE4A, PDE5A, PTGS1, PTGS2 💬 | 28件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Purine metabolism, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 49 49 |
48 | Extended release fampridine | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
49 | Extended Release Melatonin | 1件: Melatonin Melatonin (Synonym: Melatonin Rapid Release Gelcaps 10 mg) | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
50 | Extended-release oxycodone | 1件: Oxycodone Oxycodone (Synonym: Oxycodone Hydrochloride Immediate-release) | 1件: D05312
D05312
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 13 13 |
51 | Extended-release quetiapine fumarate | 1件: Quetiapine Quetiapine (Synonym: Quetiapine Fumarate Extended Release) | 1件: D08456
D08456
| 2件: DRD2 DRD2, HTR2A 💬 | 11件: Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬 | 1件: 13 13 |
52 | Fampyra 10 mg prolonged-release tablets | 2件: Dalfampridine Dalfampridine, Manganese citrate (Synonym: Release) | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
53 | Fampyra 10mg prolonged release tablets | 2件: Dalfampridine Dalfampridine, Manganese citrate (Synonym: Release) | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
54 | Firategrast immediate release tablet | 1件: Firategrast Firategrast | 1件: D06590
D06590
| 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 |
55 | Firategrast modified release tablet | 1件: Firategrast Firategrast | 1件: D06590
D06590
| 1件: ITGA4 ITGA4 💬 | 14件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 1件: 13 13 |
56 | Guanfacine Extended Release | 1件: Guanfacine Guanfacine (Synonym: Guanfacine Extended-Release) | 1件: D08031
D08031
| 1件: ADRA2A ADRA2A 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 193 193 |
57 | Guanfacine extended release (GXR) | 1件: Guanfacine Guanfacine (Synonym: Guanfacine Extended-Release) | 1件: D08031
D08031
| 1件: ADRA2A ADRA2A 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 193 193 |
58 | Hydrocortisone Modified Release Capsules | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 |
59 | IBD98-M Delayed-release Capsules | 1件: Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | 1件: 97 97 |
60 | Immediate release carbidopa/levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
61 | Immediate Release carbidopa/levodopa 10/100 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
62 | Immediate Release carbidopa/levodopa 25/100 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
63 | Immediate Release Melatonin | 1件: Melatonin Melatonin (Synonym: Melatonin Rapid Release Gelcaps 10 mg) | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
64 | KVD824 300 mg Modified Release Tablets | 1件: Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | 1件: 65 65 |
65 | Lamotrigine (Synonym: LAMOTRIGINE EXTENDED RELEASE) | 1件: Lamotrigine Lamotrigine (Synonym: Lamotrigine Extended Release) | 1件: D00354
D00354
(Name: LAMOTRIGINE EXTENDED RELEASE) | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 5件: 13 13, 34, 38, 114, 144 |
66 | Lamotrigine - generic product (Synonym: LAMOTRIGINE EXTENDED RELEASE) | 1件: Lamotrigine Lamotrigine (Synonym: Lamotrigine Extended Release) | 1件: D00354
D00354
(Name: LAMOTRIGINE EXTENDED RELEASE) | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 38 38 |
67 | Lamotrigine 25Mg Oral Tablet, Extended Release | 1件: Lamotrigine Lamotrigine (Synonym: Lamotrigine Extended Release) | 1件: D00354
D00354
(Name: LAMOTRIGINE EXTENDED RELEASE) | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 114 114 |
68 | Lamotrigine dispers (Synonym: LAMOTRIGINE EXTENDED RELEASE) | 1件: Lamotrigine Lamotrigine (Synonym: Lamotrigine Extended Release) | 1件: D00354
D00354
(Name: LAMOTRIGINE EXTENDED RELEASE) | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 34 34 |
69 | Lamotrigine extended release tablets | 1件: Lamotrigine Lamotrigine (Synonym: Lamotrigine Extended Release) | 1件: D00354
D00354
(Name: LAMOTRIGINE EXTENDED RELEASE) | 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 13 13 |
70 | Levetiracetam (Synonym: LEVETIRACETAM EXTENDED RELEASE) | 1件: Levetiracetam Levetiracetam (Synonym: Levetiracetam Extended Release) | 1件: D00709
D00709
(Name: LEVETIRACETAM EXTENDED RELEASE) | 1件: SV2A SV2A 💬 | 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 5件: 2 2, 4, 6, 13, 307 |
71 | Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
72 | Levodopa CR (controlled release) | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
73 | Levodopa-carbidopa (LC) oral encapsulated immediate release (IR) tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
74 | Levodopa-carbidopa Immediate Release (LC-IR) Tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
75 | Levodopa-Carbidopa Multilayer Extended Release Tablet | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
76 | Lodotra (delayed release prednisolone) | 1件: Prednisolone Prednisolone | 1件: D00472
D00472
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 |
77 | LPM3770164 sustained release tablet | 1件: Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | 1件: 8 8 |
78 | LPM3770164 sustained release tablet simulant | 1件: Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | 1件: 8 8 |
79 | LT-02 (modified-release PC pellets) | 1件: Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | 1件: 97 97 |
80 | LY03003 ( Rotigotine, extended-release microspheres) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
81 | LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
82 | LY03003(Rotigotine,extended-release microspheres) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
83 | Mesalamine Delayed Release Tablets 400mg | 2件: Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | 1件: D00377
D00377
| - | - | 1件: 97 97 |
84 | Mesalazine slow-release granules | 1件: Mesalazine Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | 1件: D00377
D00377
| - | - | 1件: 97 97 |
85 | Mesalazine Sustained-Release Tablets | 1件: Mesalazine Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | 1件: D00377
D00377
| - | - | 1件: 96 96 |
86 | Methylphenidate modified release | 1件: Methylphenidate Methylphenidate (Synonym: Methylphenidate Hydrochloride Extended-Release) | 1件: D04999
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 |
87 | Methylphenidate modified release 20 mg | 1件: Methylphenidate Methylphenidate (Synonym: Methylphenidate Hydrochloride Extended-Release) | 1件: D04999
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 |
88 | Methylphenidate modified release 30 mg | 1件: Methylphenidate Methylphenidate (Synonym: Methylphenidate Hydrochloride Extended-Release) | 1件: D04999
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 |
89 | Methylphenidate modified release 40 mg | 1件: Methylphenidate Methylphenidate (Synonym: Methylphenidate Hydrochloride Extended-Release) | 1件: D04999
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 |
90 | Mezavant Gastro-resistant, prolonged release tablets | 2件: Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | 1件: D00377
D00377
| - | - | 1件: 97 97 |
91 | Mezavant XL 1200 mg gastro-resistant prolonged release tablets | 2件: Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | 1件: D00377
D00377
| - | - | 1件: 97 97 |
92 | Mezavant XL 1200 mg gastro-resistant, prolonged release tablets | 2件: Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | 1件: D00377
D00377
| - | - | 1件: 97 97 |
93 | Mezavant XL 1200 mg gastro-resistant, prolonged release tablets. | 2件: Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | 1件: D00377
D00377
| - | - | 1件: 97 97 |
94 | Mezavant XL 1200mg gastro-resistant, prolonged release tablets | 2件: Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | 1件: D00377
D00377
| - | - | 1件: 97 97 |
95 | Mezavant XL Gastro-resistant, prolonged release tablets | 2件: Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | 1件: D00377
D00377
| - | - | 1件: 97 97 |
96 | MG01CI extended-release tablet | 1件: Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | 1件: 206 206 |
97 | Mirapexin extended release various strengths | 2件: Manganese citrate Manganese citrate (Synonym: Release), Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | 1件: D05575
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
98 | Modified-release phosphatidylcholine | 2件: Lecithin Lecithin, Manganese citrate (Synonym: Release) | 1件: D04682
D04682
| - | - | 1件: 97 97 |
99 | Nalbuphine Extended-Release (ER) Tablets | 1件: Nalbuphine Nalbuphine | 1件: D08246
D08246
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 85 85 |
100 | Naproxen (EC-Narosyn) Delayed Release Tables, 375 (Syntex (USA), Inc.) | 1件: Naproxen Naproxen (Synonym: Naproxen delayed release) | 1件: D00118
D00118
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
101 | Naproxen Delayed Release Tables, 375 (Gevena Pharmaceuticals, Inc.) | 1件: Naproxen Naproxen (Synonym: Naproxen delayed release) | 1件: D00118
D00118
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
102 | Octreotide LAR / Sandostatin LAR (LAR=long acting release) | 1件: Octreotide Octreotide | 1件: D00442
D00442
| 1件: SSTR2 SSTR2 💬 | 4件: Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 84 84 |
103 | Oral treprostinil (UT-15C) Sustained Release Tablets | 1件: Treprostinil Treprostinil | 1件: D06213
D06213
| 1件: PTGIR PTGIR 💬 | 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | 1件: 86 86 |
104 | Oxycodone naloxone prolonged release tablets | 2件: Naloxone Naloxone, Oxycodone (Synonym: Oxycodone Hydrochloride Immediate-release) | 2件: D05312
D05312
,
D08249
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 |
105 | Oxycodone/naloxone prolonged release t | 3件: Manganese citrate Manganese citrate (Synonym: Release), Naloxone, Oxycodone (Synonym: Oxycodone Hydrochloride Immediate-release) | 2件: D05312
D05312
,
D08249
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 |
106 | Oxycodone/Naloxone Prolonged Release tablets | 2件: Naloxone Naloxone, Oxycodone (Synonym: Oxycodone Hydrochloride Immediate-release) | 2件: D05312
D05312
,
D08249
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
107 | Oxycodone/naloxone prolonged release tablets 10 mg /5 mg | 3件: Manganese citrate Manganese citrate (Synonym: Release), Naloxone, Oxycodone (Synonym: Oxycodone Hydrochloride Immediate-release) | 2件: D05312
D05312
,
D08249
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
108 | Oxycodone/naloxone prolonged release tablets 10/5 mg | 3件: Manganese citrate Manganese citrate (Synonym: Release), Naloxone, Oxycodone (Synonym: Oxycodone Hydrochloride Immediate-release) | 2件: D05312
D05312
,
D08249
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 |
109 | Oxycodone/naloxone prolonged release tablets 20 mg /10 mg | 3件: Manganese citrate Manganese citrate (Synonym: Release), Naloxone, Oxycodone (Synonym: Oxycodone Hydrochloride Immediate-release) | 2件: D05312
D05312
,
D08249
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
110 | Oxycodone/naloxone prolonged release tablets 20/10 mg | 3件: Manganese citrate Manganese citrate (Synonym: Release), Naloxone, Oxycodone (Synonym: Oxycodone Hydrochloride Immediate-release) | 2件: D05312
D05312
,
D08249
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 |
111 | Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg | 3件: Manganese citrate Manganese citrate (Synonym: Release), Naloxone, Oxycodone (Synonym: Oxycodone Hydrochloride Immediate-release) | 2件: D05312
D05312
,
D08249
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
112 | Oxycodone/naloxone prolonged release tablets 5/2.5 mg | 3件: Manganese citrate Manganese citrate (Synonym: Release), Naloxone, Oxycodone (Synonym: Oxycodone Hydrochloride Immediate-release) | 2件: D05312
D05312
,
D08249
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 |
113 | Pancrelipase Delayed Release | 1件: Pancrelipase Pancrelipase | 1件: D05349
D05349
| - | - | 1件: 299 299 |
114 | Pancrelipase Delayed Release Capsule | 1件: Pancrelipase Pancrelipase | 1件: D05349
D05349
| - | - | 2件: 298 298, 299 |
115 | Pentasa 2g sachet prolonged release granules (95%) | 2件: Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | 1件: D00377
D00377
| - | - | 1件: 97 97 |
116 | Pentasa Compact 2g, granulate with prolonged release | 2件: Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | 1件: D00377
D00377
| - | - | 1件: 97 97 |
117 | Pentasa Compact 4g, granulate with prolonged release | 2件: Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | 1件: D00377
D00377
| - | - | 1件: 97 97 |
118 | Pentasa prolonged release granules 2g | 2件: Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | 1件: D00377
D00377
| - | - | 1件: 97 97 |
119 | Pentasa Sachet 1 g prolonged release granules | 2件: Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | 1件: D00377
D00377
| - | - | 1件: 96 96 |
120 | Plenadren 20 mg modified-release tablets | 2件: Hydrocortisone Hydrocortisone, Manganese citrate (Synonym: Release) | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 78 78 |
121 | Plenadren 5 mg modified-release tablets | 2件: Hydrocortisone Hydrocortisone, Manganese citrate (Synonym: Release) | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 78 78 |
122 | Pramipexol Extended Release | 1件: Pramipexole Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | 1件: D05575
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
123 | Pramipexol Immediate Release | 1件: Pramipexole Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | 1件: D05575
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
124 | Pramipexole dihydrochloride extended-release tablets | 1件: Pramipexole Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | 1件: D05575
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
125 | Pramipexole dihydrochloride monohydrate extended release | 2件: Manganese citrate Manganese citrate (Synonym: Release), Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | 1件: D05575
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
126 | Pramipexole Extended Release | 1件: Pramipexole Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | 1件: D05575
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
127 | Pramipexole extended release tablet | 1件: Pramipexole Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | 1件: D05575
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
128 | Pramipexole hydrochloride sustained-release tablet (Siforl®) Specification: 0.26mg/ tablet (in pramipexole) | 1件: Pramipexole Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | 1件: D05575
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
129 | Pramipexole Immediate Release | 1件: Pramipexole Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | 1件: D05575
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
130 | Pramipexole immediate release tablet | 1件: Pramipexole Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | 1件: D05575
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
131 | Praxol hydrochloride sustained release tablet Specification: 0.375mg/ tablet (in pramipexole hydrochloride) | 1件: Pramipexole Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | 1件: D05575
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
132 | Pregabalin (Synonym: PREGABALIN EXTENDED RELEASE) | 1件: Pregabalin Pregabalin (Synonym: Pregabalin Extended Release) | 1件: D02716
D02716
(Name: PREGABALIN EXTENDED RELEASE) | 4件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 | 7件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬 | 5件: 13 13, 36, 46, 70, 298 |
133 | Pregabalin 75mg (Synonym: PREGABALIN EXTENDED RELEASE) | 1件: Pregabalin Pregabalin (Synonym: Pregabalin Extended Release) | 1件: D02716
D02716
(Name: PREGABALIN EXTENDED RELEASE) | 4件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 | 7件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬 | 1件: 70 70 |
134 | Prolonged release tablet | 1件: Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | 1件: 6 6 |
135 | Prolonged-release Fampridine | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
136 | Ranolazine PR (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die | 1件: Ranolazine Ranolazine | 1件: D05700
D05700
| - | - | 1件: 58 58 |
137 | RAYOS (delayed-release prednisone) | 1件: Prednisone Prednisone | 1件: D00473
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
138 | Release | 1件: Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | 12件: 6 6, 8, 13, 46, 65, 78, 81, 96, 97, 206, 226, 299 |
139 | Requip prolonged release | 2件: Manganese citrate Manganese citrate (Synonym: Release), Ropinirole | 1件: D08489
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
140 | Requip XL prolonged-release | 2件: Manganese citrate Manganese citrate (Synonym: Release), Ropinirole | 1件: D08489
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
141 | Retarded release phosphatidylcholine | 1件: Lecithin Lecithin | 1件: D04682
D04682
| - | - | 1件: 97 97 |
142 | Retarded Release Phosphatidylcholine (rPC) | 1件: Lecithin Lecithin | 1件: D04682
D04682
| - | - | 1件: 97 97 |
143 | Rifaximin Delayed Release (DR) | 1件: Rifaximin Rifaximin | 1件: D02554
D02554
| - | - | 1件: 96 96 |
144 | Rifaximin delayed release 400 mg film coated tablet | 1件: Rifaximin Rifaximin | 1件: D02554
D02554
| - | - | 1件: 96 96 |
145 | Rifaximin delayed release tablets | 1件: Rifaximin Rifaximin | 1件: D02554
D02554
| - | - | 1件: 96 96 |
146 | Ropinirole controlled-release (REQUIP CR) for RLS | 1件: Ropinirole Ropinirole | 1件: D08489
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
147 | Ropinirole hydrochloride extended-release tablet | 1件: Ropinirole Ropinirole | 1件: D08489
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
148 | Ropinirole hydrochloride extended-release tablet placebo | 1件: Ropinirole Ropinirole | 1件: D08489
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
149 | Ropinirole hydrochloride prolonged release | 2件: Manganese citrate Manganese citrate (Synonym: Release), Ropinirole | 1件: D08489
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
150 | Ropinirole immediate release | 1件: Ropinirole Ropinirole | 1件: D08489
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
151 | Ropinirole Prolonged release | 1件: Ropinirole Ropinirole | 1件: D08489
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
152 | Ropinirole prolonged release/extended release(PR/XR) | 1件: Ropinirole Ropinirole | 1件: D08489
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
153 | Rosiglitazone Extended Release Tablets | 1件: Rosiglitazone Rosiglitazone | 1件: D08491
D08491
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 46 46 |
154 | Rotigotine, extended-release microspheres | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
155 | Salofalk 3g gastro-resistant prolonged-release granules | 2件: Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | 1件: D00377
D00377
| - | - | 1件: 97 97 |
156 | Sinemet CR 25Mg-100Mg Extended-Release Tablet | 3件: Carbidopa Carbidopa, Levodopa, Manganese citrate (Synonym: Release) | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
157 | Sinemet® controlled release (Carbidopa/levodopa) | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
158 | SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine | 1件: Mesalazine Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | 1件: D00377
D00377
| - | - | 1件: 97 97 |
159 | Sustained release growth hormone | 1件: Somatotropin Somatotropin | - | - | - | 1件: 78 78 |
160 | Sustained-release oral dalfampridine | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 |
161 | Sustained-release recombinant human GH (SR-rhGH) | 1件: Somatotropin Somatotropin | - | - | - | 1件: 78 78 |
162 | Tacrolimus prolonged-release hard capsules | 2件: Manganese citrate Manganese citrate (Synonym: Release), Tacrolimus | 2件: D00107
D00107
,
D08556
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 |
163 | Targinact 10 mg/5 mg prolonged-release tablets | 1件: Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | 2件: 6 6, 226 |
164 | Targinact 20 mg/10 mg prolonged-release tablets | 1件: Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | 1件: 6 6 |
165 | Targinact 20mg/10 mg prolonged-release tablets | 1件: Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | 1件: 226 226 |
166 | Targinact 5 mg/2.5 mg prolonged-release tablets | 1件: Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | 1件: 6 6 |
167 | Targinact 5mg/2.5 mg prolonged-release tablets | 1件: Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | 1件: 226 226 |
168 | Tofacitinib (Xeljanz®) 11mg Prolonged Release Tablet | 1件: Tofacitinib Tofacitinib | 1件: D09970
D09970
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬 | 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 |
169 | WD-1603 CARBIDOPA and LEVODOPA EXTENDED-RELEASE TABLETS | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
170 | WD-1603 Carbidopa-Levodopa Extended-Release Tablets | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
171 | WD-1603 CARBIDOPA/LEVODOPA EXTENDED-RELEASE TABLETS | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
172 | Xeljanz® 11mg Prolonged Release Tablet | 2件: Manganese citrate Manganese citrate (Synonym: Release), Tofacitinib | 1件: D09970
D09970
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬 | 37件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 46 46 |